Drug

BELANTAMAB MAFODOTIN

Drug TypeAction TypeMechanism of ActionApprovedMax Trial PhaseMax GBM Phase
Antibody BINDING AGENT Tumor necrosis factor receptor superfamily member 17 binding agent no 4 0